EVOPOINT BIOSCIENCES CO LTD
SSSE:688837Share Statistics
As of June 30, 2026, EVOPOINT BIOSCIENCES CO LTD has 435.49M shares outstanding.
| Shares Outstanding | 435.49M |
Financial Position
As of June 30, 2026, EVOPOINT BIOSCIENCES CO LTD maintains a current ratio of 2.00, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.00 |
| Quick Ratio | 1.79 |
| Debt / Equity | 241.64 |
Financial Efficiency
CNYThese figures cover the twelve months ended June 30, 2026. The company generates approximately 474,867.14 in revenue per employee across its workforce of 362.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 474,867.14 |
| Employee Count | 362.00 |
Income Statement
CNYThese figures cover the twelve months ended June 30, 2026.
| Gross Profit | 171.90M |
| Pretax Income | -3.45M |
Balance Sheet
CNYAs of June 30, 2026, EVOPOINT BIOSCIENCES CO LTD holds 983.36M in cash and equivalents against 1.29B in total debt, resulting in a net debt position of 31.69M. Total book value stands at 535.59M, with working capital of 545.43M providing operational flexibility.
| Cash & Cash Equivalents | 983.36M |
| Total Debt | 1.29B |
| Net Debt | 31.69M |
| Equity (Book Value) | 535.59M |
| Book Value Per Share | 1.23 |
| Working Capital | 545.43M |
Margins
These figures cover the twelve months ended June 30, 2026. The operating margin of -93.36 and net profit margin of -11.98 provide insight into operational efficiency.
| Operating Margin | -93.36 |
| Pretax Margin | -2.01 |
| Profit Margin | -11.98 |